REFERENCES
- Ros HS, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol 1998;147: 1062–1070.
- American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care 2004;27: 88–90.
- Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslen B, Marsal K, Hansson SR. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Placenta 2004;25: 518–529.
- Nguyen TT, Tseng YT, McGonnigal B, Stabila JP, Worrell LA, Saha S, Padbury JF. Placental biogenic amine transporters: in vivo function, regulation and pathobiological significance. Placenta 1999;20:3–11.
- Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 2001;91:35–62.
- Falkay G, Kovács L. Expression of two alpha 2–adrenergic receptor subtypes in human placenta: evidence from direct binding studies. Placenta 1994:15:661–668.
- Hellgren I, Sylven C, Magnusson Y. Study of the beta1 adrenergic receptor expression in human tissues: immunological approach. Biol Pharm Bull 2000;23:700–703.
- Schocken DD, Caron MG, Lefkowitz RJ. The human placenta–a rich source of beta-adrenergic receptors: characterization of the receptors in particulate and solubilized preparations. J Clin Endocrinol Metab 1980;50:1082–1088.
- Resch BE, Ducza E, Gaspar R, Falkay G, Role of adrenergic receptor subtypes in the control of human placental blood vessels. Mol Reprod Dev 2003;66:166–171.
- Bzoskie L, Yen J, Tseng YT, Blount L, Kashiwai K, Padbury JF. Human placental norepinephrine transporter mRNA: expression and correlation with fetal condition at birth. Placenta 1997;18:205–213.
- Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Eng J Med 2000;342:541–549.
- Urwin RE, Bennetts B, Wilcken B, Lampropoulos B, Beumont P, Clarke S, Russell J, Tanner S, Nunn KP. Anorexia nervosa (restrictive subtype) is associated with a polymorphism in the novel norepinephrine transporter gene promoter polymorphic region. Molec Psychiat 2002;7: 652–657.
- De Maria FJ, See HY. Role of the placenta in the preeclampsia. Am J Obste Gynecol 1996;94:471–476.
- American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of hypertension. Endocr Pract 2006;12:193–222.
- Ciechanowicz A. Gene therapy perspectives apllied to arterial hypertension. Med Pract 2002;315–322.